Literature DB >> 21813664

A conformational change of C fragment of tetanus neurotoxin reduces its ganglioside-binding activity but does not destroy its immunogenicity.

Rui Yu1, Shaoqiong Yi, Changming Yu, Ting Fang, Shuling Liu, Ting Yu, Xiaohong Song, Ling Fu, Lihua Hou, Wei Chen.   

Abstract

The C fragment of tetanus neurotoxin (TeNT-Hc) with different conformations was observed due to the four cysteine residues within it which could form different intramolecular disulfide bonds. In this study, we prepared and compared three types of monomeric TeNT-Hc with different conformational components: free sulfhydryls (50 kDa), bound sulfhydryls (44 kDa), and a mixture of the two conformational proteins (half 50 kDa and half 44 kDa). TeNT-Hc with bound sulfhydryls reduced its binding activity to ganglioside G(T1b) and neuronal PC-12 cells compared to what was seen for TeNT-Hc with free sulfhydryls. However, there was no significant difference among their immunogenicities in mice, including induction of antitetanus toxoid IgG titers, antibody types, and protective capacities against tetanus neurotoxin challenge. Our results showed that the conformational changes of TeNT-Hc resulting from disulfide bond formation reduced its ganglioside-binding activity but did not destroy its immunogenicity, and the protein still retained continuous B cell and T cell epitopes; that is, the presence of the ganglioside-binding site within TeNT-Hc may be not essential for the induction of a fully protective antitetanus response. TeNT-Hc with bound sulfhydryls may be developed into an ideal human vaccine with a lower potential for side effects.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21813664      PMCID: PMC3187031          DOI: 10.1128/CVI.05244-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  18 in total

1.  Crystallization and preliminary X-ray analysis of tetanus neurotoxin C fragment.

Authors:  T C Umland; L Wingert; S Swaminathan; J J Schmidt; M Sax
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1998-03-01

2.  Construction of hybrid proteins that migrate retrogradely and transynaptically into the central nervous system.

Authors:  L Coen; R Osta; M Maury; P Brûlet
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

3.  The HC fragment of tetanus toxin forms stable, concentration-dependent dimers via an intermolecular disulphide bond.

Authors:  Omar Qazi; Barbara Bolgiano; Dennis Crane; Dmitri I Svergun; Petr V Konarev; Zhong-Ping Yao; Carol V Robinson; Katherine A Brown; Neil Fairweather
Journal:  J Mol Biol       Date:  2006-09-23       Impact factor: 5.469

4.  Instruments for oral disease-intervention strategies: recombinant Lactobacillus casei expressing tetanus toxin fragment C for vaccination or myelin proteins for oral tolerance induction in multiple sclerosis.

Authors:  C B Maassen; J D Laman; M J den Bak-Glashouwer; F J Tielen; J C van Holten-Neelen; L Hoogteijling; C Antonissen; R J Leer; P H Pouwels; W J Boersma; D M Shaw
Journal:  Vaccine       Date:  1999-04-23       Impact factor: 3.641

Review 5.  Performance and potency of tetanus toxoid: implications for eliminating neonatal tetanus.

Authors:  V Dietz; J B Milstien; F van Loon; S Cochi; J Bennett
Journal:  Bull World Health Organ       Date:  1996       Impact factor: 9.408

6.  Structure of the receptor binding fragment HC of tetanus neurotoxin.

Authors:  T C Umland; L M Wingert; S Swaminathan; W F Furey; J J Schmidt; M Sax
Journal:  Nat Struct Biol       Date:  1997-10

7.  Reduction of the ganglioside binding activity of the tetanus toxin HC fragment destroys immunogenicity: implications for development of novel tetanus vaccines.

Authors:  Omar Qazi; Dorothea Sesardic; Robert Tierney; Zahra Söderbäck; Dennis Crane; Barbara Bolgiano; Neil Fairweather
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

8.  Analysis of the immune response to papain digestion products of tetanus toxin.

Authors:  T B Helting; H H Nau
Journal:  Acta Pathol Microbiol Immunol Scand C       Date:  1984-02

9.  Retrograde transneuronal transfer of the C-fragment of tetanus toxin.

Authors:  P S Fishman; D R Carrigan
Journal:  Brain Res       Date:  1987-03-17       Impact factor: 3.252

10.  Functional characterisation of tetanus and botulinum neurotoxins binding domains.

Authors:  G Lalli; J Herreros; S L Osborne; C Montecucco; O Rossetto; G Schiavo
Journal:  J Cell Sci       Date:  1999-08       Impact factor: 5.285

View more
  4 in total

1.  The Pneumococcal Polysaccharide-Tetanus Toxin Native C-Fragment Conjugate Vaccine: The Carrier Effect and Immunogenicity.

Authors:  Rui Yu; Junjie Xu; Tao Hu; Wei Chen
Journal:  Mediators Inflamm       Date:  2020-07-04       Impact factor: 4.711

2.  Characterization and evaluation of the enzymatic activity of tetanus toxin submitted to cobalt-60 gamma radiation.

Authors:  Giselle Pacifico Sartori; Andréa da Costa; Fernanda Lúcio Dos Santos Macarini; Douglas Oscar Ceolin Mariano; Daniel Carvalho Pimenta; Patrick Jack Spencer; Luiz Henrique da Silva Nali; Andrés Jimenez Galisteo
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2021-04-30

3.  The Immunogenicity of the C Fragment of Tetanus Neurotoxin in Production of Tetanus Antitoxin.

Authors:  Rui Yu; Chong Ji; Junjie Xu; Denghai Wang; Ting Fang; Yue Jing; Clifton Kwang-Fu Shen; Wei Chen
Journal:  Biomed Res Int       Date:  2018-12-31       Impact factor: 3.411

Review 4.  Designs of Antigen Structure and Composition for Improved Protein-Based Vaccine Efficacy.

Authors:  Kyle Saylor; Frank Gillam; Taylor Lohneis; Chenming Zhang
Journal:  Front Immunol       Date:  2020-02-24       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.